COMIRNATY

Google image searchProduct monograph

Active ingredient

*sarscov2 s-protein mrna, 5'[m27,3'-ogppp(m12'-o)apg], 3'polya+linker, 10 MCG/0.3 ML

DIN: 02541858

Dosage form(s): SUSPENSION

Route(s) of administration: INTRAMUSCULAR

Description: SINGLE DOSE VIAL AND MULTIDOSE VIAL

Schedule: Schedule D

Company: BIONTECH MANUFACTURING GMBH

Date: 24-SEP-2024

ATC:

Reference brand drug: Comirnaty, Spikevax

Search on Google